$-0.22
(Market cap
$9 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-7 Mln
-
ROE
-2.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.7
-
Debt to Equity
-0.1
-
Book Value
$--
-
EPS
$-4.3
-
Face value
--
-
Shares outstanding
5,850,906
10 Years Aggregate
CFO
$-118.16 Mln
EBITDA
$-128.19 Mln
Net Profit
$-126.82 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Check-Cap - ADR (CHEK)
| 24.6 | 23.8 | 30.8 | 74.8 | -12.0 | -42.2 | -42.0 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Check-Cap - ADR (CHEK)
| 68.7 | -5.5 | -83.7 | 46.7 | -73.3 | -20.0 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Check-Cap - ADR (CHEK)
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
-
CEO & Director
Mr. Alex Ovadia
-
CEO & Director
Mr. Alex Ovadia
-
Headquarters
Isfiya
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Check-Cap - ADR (CHEK)
What is the current share price of Check-Cap Ltd - ADR (CHEK) Today?
The share price of Check-Cap Ltd - ADR (CHEK) is $2.08 (NASDAQ) as of 28-Jan-2026 09:30 EDT. Check-Cap Ltd - ADR (CHEK) has given a return of -11.98% in the last 3 years.
What is the current PB & PE ratio of Check-Cap Ltd - ADR (CHEK)?
Since, TTM earnings of Check-Cap Ltd - ADR (CHEK) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.39 |
-6.73 |
2024 |
-0.23 |
-3.99 |
2023 |
-0.69 |
0.51 |
2022 |
-0.67 |
0.31 |
2021 |
-0.19 |
0.06 |
What is the 52 Week High and Low of Check-Cap Ltd - ADR (CHEK)?
The 52-week high and low of Check-Cap Ltd - ADR (CHEK) are Rs 182.00 and Rs 0.59 as of 30-Aug-2026.
What is the market cap of Check-Cap Ltd - ADR (CHEK)?
Check-Cap Ltd - ADR (CHEK) has a market capitalisation of $ 9 Mln as on 27-Apr-2026. As per SEBI classification, it is a company.
Should I invest in Check-Cap Ltd - ADR (CHEK)?
Before investing in Check-Cap Ltd - ADR (CHEK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.